Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 24, 2024CellOpen Access

Pan-cancer proteogenomics expands the landscape of therapeutic targets

View Full Paper
Ask AI
Bookmark
Share

Authors

SSSara R. SavageBaylor College of MedicineXYXinpei YiChinese Academy of SciencesJLJonathan T. LeiBaylor College of Medicine

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Savage et al. (2024) studied this question.

synapsesocial.com/papers/68e637ebb6db6435875c958fhttps://doi.org/10.1016/j.cell.2024.05.039
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1MAGE‐A10 is a nuclear protein frequently expressed in high percentages of tumor cells in lung, skin and urothelial malignancies2010 · 55 citations
  2. 2OptiType: precision HLA typing from next-generation sequencing data2014 · 857 citations
  3. 3The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes.1994 · 850 citations